Vai al contenuto
Claris Ventures
  • Home
  • About us
    • Strategy
    • Team
  • Portfolio
  • News
  • Careers
Cerca
Claris Ventures
Chiudi menu
  • Home
  • About us
    • Strategy
    • Team
  • Portfolio
  • News
  • Careers
Claris Ventures
Cerca Mostra/Nascondi menu

Autore: admin

Aprile 7, 2020Aprile 7, 2020Report

COVID-19: Claris Ventures publishes its report on vaccines and drugs in development

Covid-19: new report from Claris Ventures on development of drugs and vaccines Claris Ventures pubblished a Vaccines & Treatments Development Snapshot for […]

Aprile 7, 2020Aprile 7, 2020Interviews

Business Insider: Claris, il primo fondo di venture capital italiano che investe solo nel biotech tricolore

Ciro Spedaliere - Managing Partner Claris Ventures

Business Insider: Claris, il primo fondo di venture capital italiano che investe solo nel biotech tricolore Ciro Spedaliere, Managing Partner of Claris […]

Febbraio 14, 2020Febbraio 14, 2020Events

VentureUp Forum 2020

VentureUp Forum 2020

Ciro Spedaliere from Claris Ventures in the Life Science Panel of Aifi VentureUp Forum 2020 Ciro Spedaliere, Partner of Claris Ventures, will […]

Novembre 16, 2019Novembre 17, 2019Events

Claris Ventures special guest at 39° Congresso Nazionale della Società Italiana di Farmacologia (SIF)

Claris Ventures 39 Convegno SIF

Claris Ventures special guest at 39° Congresso Nazionale della Società Italiana di Farmacologia (SIF) The 39° National Congress of the Italian Pharmacology […]

Ottobre 25, 2019Novembre 17, 2019Partnership

Claris Ventures joins Torino City Lab

Claris Ventures partnership Torino CIty Lab

Claris Ventures joins Torino City Lab

Luglio 5, 2019Novembre 17, 2019Investments

Kither Biotech raises a €5.6m financing round to support the clinical development of a new drug for cystic fibrosis and other pulmonary diseases

Kither Biotech Investment round

Kither Biotech raises a €5.6m financing round to support the clinical development of a new drug for cystic fibrosis and other pulmonary […]

Maggio 20, 2019Febbraio 14, 2020Events

Claris Ventures guest speaker at “The drug from basic research to therapy” convention organized by the Italian Society of Pharmacology

Claris Ventures ospite a Il Farmaco dalla Ricerca di Base alla Terapia

Claris Ventures guest speaker at “The drug from basic research to therapy” convention organized by the Italian Society of Pharmacology

Maggio 2, 2019Novembre 17, 2019Interviews

Pietro Puglisi from Claris Ventures interviewed by national TV

Pietro Puglisi interviewed by RAI

Pietro Puglisi of Claris Ventures, interviewed by national TV RAI

Paginazione degli articoli

< 1 2

Articoli recenti

  • Claris Ventures and Evotec Forge Powerful Partnership to Fast-Track Portfolio Programs Into Clinical Advancement
  • Claris Ventures appoints pharmaceutical industry veteran Michael Hodges as a Partner
  • Sibylla Biotech raises €23 Million Series A
  • Iama therapeutics raises €8 Million Series A
  • Hequet Therapeutics raises €8 million

Commenti recenti

    Archivi

    • Marzo 2024
    • Febbraio 2023
    • Gennaio 2023
    • Marzo 2022
    • Luglio 2021
    • Marzo 2021
    • Settembre 2020
    • Aprile 2020
    • Febbraio 2020
    • Novembre 2019
    • Ottobre 2019
    • Luglio 2019
    • Maggio 2019

    Categorie

    • Events
    • Interviews
    • Investments
    • News
    • Partnership
    • Report
    • Uncategorized

    Meta

    • Accedi
    • Feed dei contenuti
    • Feed dei commenti
    • WordPress.org

    Links

    • Claris Ventures
    • Team
    • About us
    • Strategy
    • Privacy Policy
    • Terms of Service
    • Careers
    • Trasparenza
    • ESG
    • Portfolio

    Contacts

    Piazza San Carlo 206, Torino, Italy
    +39 (0) 11 3325889
    info@clarisventures.com

    Arbitro per le Controversie Finanziarie

    VAT: 12116290011

    PEC: clarisventures.pec [at] maildoc.it

    Stay in touch with Claris Ventures

    Sign up for our newsletter to stay up to date on news from Claris, and our portfolio.

    © 2025 Claris Ventures. Proudly powered by Sydney